Munson Medical Center
- Type
- Teaching hospital
- Where
- Traverse City, MI
- Medicare CCN
- 230097
- Received
- $410,650 in 44 records, 2025 ($19,410 general, $391,240 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: MUNSON MEDICAL CENTER,CORPORATION Fuzzy (name and state)
- Nonprofit contractor: MUNSON MEDICAL CENTER Fuzzy (name and state)
- Plan sponsor: MUNSON MEDICAL CENTER Fuzzy (name and state)
- Federal award recipient: MUNSON MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: MUNSON MEDICAL CENTER Fuzzy (name and state)
- Nonprofit: MUNSON MEDICAL CENTER Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 32 | $19,410 |
| 2025 | Research payment | 12 | $391,240 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $327,203 | 2025 |
| MicroVention, Inc. | 5 | $43,716 | 2025 |
| Amgen Inc. | 1 | $17,976 | 2025 |
| Tandem Diabetes Care, Inc. | 24 | $11,900 | 2025 |
| Siemens Medical Solutions USA, Inc. | 3 | $4,198 | 2025 |
| Rapid Medical Ltd | 3 | $1,845 | 2025 |
| Organon Llc | 2 | $1,740 | 2025 |
| Linvatec Corporation | 1 | $800 | 2025 |
| Imperative Care, Inc | 1 | $500 | 2025 |
| Aesculap, Inc. | 1 | $427 | 2025 |
| Stryker Corporation | 1 | $342 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 12 | $391,240 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 24 | $11,900 |
| Grant | 2 | $4,160 |
| Long term medical supply or device loan | 4 | $2,883 |
| Debt forgiveness | 2 | $466 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Stryker Corporation | $342 | Long term medical supply or device loan | In-kind items and services | COMFORTGEL Device, PATIENT HANDLING - PH | 2025 | |
| 2025-12-31 | Siemens Medical Solutions USA, Inc. | $38 | Debt forgiveness | In-kind items and services | 2025 | ||
| 2025-12-03 | Tandem Diabetes Care, Inc. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-11-12 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-11-05 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-10-22 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-10-08 | Tandem Diabetes Care, Inc. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-10-01 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-09-24 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-09-17 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-09-03 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-08-20 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-08-06 | Tandem Diabetes Care, Inc. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-08-05 | AstraZeneca Pharmaceuticals LP | $9,615 | Research payment | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | Dapagliflozin in Acute Decompensated Heart Failure | 2025 |
| 2025-07-24 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-07-16 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-07-16 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-06-27 | Aesculap, Inc. | $427 | Debt forgiveness | Cash or cash equivalent | 2025 | ||
| 2025-06-18 | Tandem Diabetes Care, Inc. | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-06-02 | Organon Llc | $1,699 | Long term medical supply or device loan | In-kind items and services | JADA SYSTEM Device, POSTPARTUM UTERINE HEMORRHAGING | 2025 | |
| 2025-06-02 | Rapid Medical Ltd | $500 | Research payment | Cash or cash equivalent | TIGERTRIEVER 17 REVASCULARIZATION DEVICE Device, Neurovascular | DISTALS Study USA | 2025 |
| 2025-05-28 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-05-27 | Siemens Medical Solutions USA, Inc. | $3,120 | Grant | In-kind items and services | 2025 | ||
| 2025-05-27 | Siemens Medical Solutions USA, Inc. | $1,040 | Grant | In-kind items and services | 2025 | ||
| 2025-05-01 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-04-24 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-04-23 | MicroVention, Inc. | $5,538 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2025 |
| 2025-04-09 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-03-19 | Organon Llc | $41 | Long term medical supply or device loan | In-kind items and services | JADA SYSTEM Device, POSTPARTUM UTERINE HEMORRHAGING | 2025 | |
| 2025-03-12 | Tandem Diabetes Care, Inc. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-03-12 | Imperative Care, Inc | $500 | Research payment | Cash or cash equivalent | ZOOM 88-T LARGE DISTAL PLATFORM Device, VASCULAR | THE IMPERATIVE TRIAL: TREATMENT OF ACUTE ISCHEMIC STROKE WITH THE ZOOM REPERFUSION SYSTEM | 2025 |
| 2025-03-05 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-02-26 | MicroVention, Inc. | $2,000 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2025 |
| 2025-02-19 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-02-13 | MicroVention, Inc. | $20,116 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2025 |
| 2025-02-13 | MicroVention, Inc. | $1,000 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2025 |
| 2025-02-12 | Tandem Diabetes Care, Inc. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-02-05 | Linvatec Corporation | $800 | Long term medical supply or device loan | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | 2025 | |
| 2025-02-05 | Tandem Diabetes Care, Inc. | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2025 | |
| 2025-02-04 | Rapid Medical Ltd | $845 | Research payment | Cash or cash equivalent | TIGERTRIEVER 17 REVASCULARIZATION DEVICE Device, Neurovascular | DISTALS Study USA | 2025 |
| 2025-02-04 | Rapid Medical Ltd | $500 | Research payment | Cash or cash equivalent | TIGERTRIEVER 17 REVASCULARIZATION DEVICE Device, Neurovascular | DISTALS Study USA | 2025 |
| 2025-01-23 | MicroVention, Inc. | $15,061 | Research payment | Cash or cash equivalent | SOFIA 6F-131CM STR Device, NEUROLOGICAL PRODUCT | SOFIA ASPIRATION SYSTEM AS FIRST LINE TECHNIQUE | 2025 |
| 2025-01-16 | Amgen Inc. | $17,976 | Research payment | In-kind items and services | REPATHA Biological, Cardiovascular | A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiova | 2025 |
| 2025-01-03 | AstraZeneca Pharmaceuticals LP | $317,588 | Research payment | Cash or cash equivalent | DATROWAY Biological, Oncology | A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato DXd) Plus Durvalumab Followed by A | 2025 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Traverse City, MI, county Grand Traverse County, MI, state Michigan; placed by its city name.
| Measure | Place (city or town) Traverse City, MI | County Grand Traverse County, MI | State Michigan |
|---|---|---|---|
| Population B01003 | 15,593 | 96,166 | 10,077,761 |
| Population, 2020 census P1 | 15,678 | 95,238 | 10,077,331 |
| Median age B01002 | 42.7 | 43.5 | 40.2 |
| Under 18 B01001 | 16.6% | 19.4% | 21.2% |
| 65 and over B01001 | 23.9% | 22.0% | 18.6% |
| Households B11001 | 7,191 | 40,287 | 4,076,369 |
| Foreign born B05002 | 2.5% | 2.0% | 7.2% |
| Median household income B19013 | $74,087 | $81,647 | $72,875 |
| Median family income B19113 | $106,362 | $101,748 | $93,357 |
| Per capita income B19301 | $53,432 | $45,034 | $40,735 |
| Poverty rate B17001 | 12.3% | 9.6% | 13.2% |
| Unemployment rate B23025 | 5.2% | 3.8% | 5.7% |
| Civilian labor force B23025 | 8,267 | 50,787 | 5,018,449 |
| Mean commute (minutes) B08013 | 17.2 | 20.6 | 24.2 |
| Bachelor's degree or higher B15003 | 47.4% | 40.6% | 32.4% |
| Housing units B25001 | 8,479 | 47,003 | 4,622,236 |
| Owner-occupied B25003 | 63.7% | 77.2% | 73.2% |
| Renters B25003 | 36.3% | 22.8% | 26.8% |
| Median home value B25077 | $415,400 | $339,400 | $231,600 |
| Median gross rent B25064 | $995 | $1,288 | $1,129 |
| White, not Hispanic B03002 | 87.7% | 90.5% | 72.4% |
| Black B03002 | 1.3% | 0.8% | 13.1% |
| Hispanic or Latino B03002 | 3.6% | 3.4% | 5.9% |
| Asian B03002 | 1.1% | 0.7% | 3.4% |
| American Indian and Alaska Native B03002 | 0.2% | 0.4% | 0.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Traverse City, MI.
Comments